Loading...

TIVC TIVIC HEALTH SYSTEMS INC US FDA Inspections 8-K Filing

TVC

TVC

TIVIC HEALTH SYSTEMS INC

(TIVC)

2025 8-K

Show Summary

Show Summary

Product Updates

Investor Meetings

Investor Meetings

Financial Statements

Equity Offerings

Equity Distribution

Nasdaq Compliance

License Agreement

Equity Purchase Agreement

New Data Release

Management Change

License Agreement

Stockholder Meeting

Nasdaq Compliance

Stockholder Letter

Q3 Financial Results

Clinical Approval

Strategic Partnership

Management Changes

Q2 Financial Results

Equity Incentive Plan

Termination of Agreement

Appointment and Resignation

Termination of Sublease Agr...

Collaboration Agreement

Securities Purchase Agreement

Earnings Release

Termination of Employment A...

Agreement with InStep health

Reverse Stock Split

Special Meeting of Stockhol...

Securities Purchase Agreement

US Patent Issuance

Delisting Notice

Equity Offerings

Annual Meeting Adjournment ...

Adjournment of Annual Meeting

Earnings Report

Resignation and Appointment

Research Collaboration Anno...

Financial Results and Corpo...

Public Offering

External Links:

On April 22, 2025, Tivic Health Systems announced that on April 17, 2025, they briefed White House leadership and met with the FDA about their TLR5 drug candidate and non-invasive technology for treating acute radiation syndrome.

AI Assistant

TIVIC HEALTH SYSTEMS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.